Patient-centered outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma Meeting Abstract


Authors: Bedel, D. J.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; Holloway, R. W.; Amenedo Gancedo, M.; Fong, P. C.; O'Malley, D. M.; Meunier, J.; Goble, S.; Cameron, T.; Mörk, A. C.; Ledermann, J. A.; Coleman, R. L.
Abstract Title: Patient-centered outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
Meeting Title: ISPOR 2019
Journal Title: Value in Health
Volume: 22
Issue: Suppl. 2
Meeting Dates: 2019 May 18-22
Meeting Location: New Orleans, LA
ISSN: 1098-3015
Publisher: Elsevier Science, Inc.  
Date Published: 2019-05-01
Start Page: S112
Language: English
ACCESSION: WOS:000472670101007
DOI: 10.1016/j.jval.2019.04.414
PROVIDER: wos
Notes: Meeting Abstract: PCN295 -- Source: Wos
Altmetric Score
MSK Authors